Free Trial

USANA Health Sciences (USNA) News Today

USANA Health Sciences logo
$36.17 -0.22 (-0.60%)
As of 01/3/2025 04:39 PM Eastern
Usana price target raised to $38 from $35 at DA Davidson
USANA Health Sciences (NYSE:USNA) Price Target Raised to $38.00
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Price Target Raised to $38.00 at DA Davidson
DA Davidson boosted their target price on shares of USANA Health Sciences from $35.00 to $38.00 and gave the stock a "neutral" rating in a research report on Thursday.
USANA Health Sciences, Inc. stock logo
Barclays PLC Acquires 14,647 Shares of USANA Health Sciences, Inc. (NYSE:USNA)
Barclays PLC raised its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 111.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,737 shares of the company's stock after purchasing an addi
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Upgraded at StockNews.com
StockNews.com upgraded shares of USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a research note on Saturday.
USANA Health Sciences, Inc. stock logo
Sidoti Csr Has Optimistic Outlook of USNA Q1 Earnings
USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Analysts at Sidoti Csr raised their Q1 2025 EPS estimates for USANA Health Sciences in a research report issued to clients and investors on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now anticipates that the company will post
USANA Health Sciences, Inc. stock logo
Equities Analysts Set Expectations for USNA Q1 Earnings
USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Equities researchers at Sidoti Csr increased their Q1 2026 earnings per share (EPS) estimates for USANA Health Sciences in a research report issued on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now expects that the company wi
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Shares Up 4.9% - Here's What Happened
USANA Health Sciences (NYSE:USNA) Trading Up 4.9% - Still a Buy?
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Shares Gap Down - Should You Sell?
USANA Health Sciences (NYSE:USNA) Shares Gap Down - Here's What Happened
USANA Health Expands with Hiya Health Acquisition
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Upgraded by DA Davidson to Hold Rating
DA Davidson upgraded shares of USANA Health Sciences to a "hold" rating in a research note on Friday.
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Reaches New 12-Month Low - Here's What Happened
USANA Health Sciences (NYSE:USNA) Sets New 1-Year Low - Here's Why
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Rating Increased to Strong-Buy at StockNews.com
StockNews.com upgraded shares of USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a report on Thursday.
Take Charge of Your Health with Genuine USANA Products
USANA Health Sciences, Inc. stock logo
Charles Schwab Investment Management Inc. Sells 29,910 Shares of USANA Health Sciences, Inc. (NYSE:USNA)
Charles Schwab Investment Management Inc. decreased its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 14.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owne
USANA Health Sciences, Inc. stock logo
USANA Health Sciences, Inc. (NYSE:USNA) Shares Sold by Jacobs Levy Equity Management Inc.
Jacobs Levy Equity Management Inc. lowered its position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 19.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 110,486 shares of the comp
USANA Health Sciences, Inc. stock logo
Pacer Advisors Inc. Has $20.64 Million Stake in USANA Health Sciences, Inc. (NYSE:USNA)
Pacer Advisors Inc. lifted its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 16.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 544,256 shares of the company's stock aft
USANA Named Top Manufacturer in Utah for Third Time
USANA Health Sciences, Inc. stock logo
Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells 675 Shares of Stock
USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) Director Gilbert A. Fuller sold 675 shares of the stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
USANA Health Sciences, Inc. stock logo
Allspring Global Investments Holdings LLC Buys 38,547 Shares of USANA Health Sciences, Inc. (NYSE:USNA)
Allspring Global Investments Holdings LLC boosted its position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 14,068.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 38,821 shares of the compan
USANA Health Sciences, Inc. stock logo
USANA Health Sciences, Inc. (NYSE:USNA) Shares Purchased by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. lifted its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 13.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 124,008 shares of the company's stock after purchasi
USANA Health Sciences, Inc. stock logo
Equities Analysts Offer Predictions for USNA Q4 Earnings
USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Investment analysts at DA Davidson issued their Q4 2024 EPS estimates for shares of USANA Health Sciences in a research note issued to investors on Wednesday, October 23rd. DA Davidson analyst L. Weiser expects that the company will earn $0.
USANA Health Sciences, Inc. stock logo
DA Davidson Issues Pessimistic Forecast for USNA Earnings
USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Research analysts at DA Davidson reduced their FY2024 earnings per share estimates for USANA Health Sciences in a report released on Wednesday, October 23rd. DA Davidson analyst L. Weiser now anticipates that the company will earn $2.45 per
Usana price target lowered to $35 from $38 at DA Davidson
USANA Health (USNA) Receives a Hold from D.A. Davidson
USANA Health Sciences Reports Decline In Q3 Income, But Beats Estimates
USANA (NYSE:USNA) Misses Q3 Revenue Estimates
USANA Health Faces Q3 2024 Sales Decline Amid Challenges
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Shares Up 4.3% Following Better-Than-Expected Earnings
USANA Health Sciences (NYSE:USNA) Shares Up 4.3% After Better-Than-Expected Earnings
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Announces Earnings Results
USANA Health Sciences (NYSE:USNA - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analysts' expectations of $208.45 million. USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. During the same period last year, the firm posted $0.59 earnings per share.
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Price Target Lowered to $35.00 at DA Davidson
DA Davidson lowered their price target on shares of USANA Health Sciences from $38.00 to $35.00 and set a "neutral" rating on the stock in a research report on Wednesday.
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Updates FY 2024 Earnings Guidance
USANA Health Sciences (NYSE:USNA) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.450-2.450 for the period, compared to the consensus estimate of 2.500. The company also issued revenue guidance of $850.0 millionillion-$850.0 millionillion, compared to the consensus estimate of $861.9 millionillion.
USANA Health Sciences, Inc. stock logo
USANA Health Sciences (NYSE:USNA) Sets New 1-Year Low - Time to Sell?
USANA Health Sciences (NYSE:USNA) Reaches New 52-Week Low - Here's Why
Get USANA Health Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.


USNA Media Mentions By Week

USNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

USNA
News Sentiment

0.61

0.87

Average
Medical
News Sentiment

USNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

USNA Articles
This Week

7

3

USNA Articles
Average Week

Get USANA Health Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:USNA) was last updated on 1/6/2025 by MarketBeat.com Staff
From Our Partners